TY - JOUR
T1 - May Measurement Month 2021
T2 - an analysis of blood pressure screening results from the UK and Republic of Ireland
AU - Lee, Shaun C.
AU - Warrington, Daniel
AU - Beaney, Thomas
AU - Cockcroft, John R.
AU - Pugh, Christopher J.A.
AU - Williams, Abbie
AU - Olding, Tyler
AU - Dolan, Eamon
AU - O'Brien, Eoin
AU - Hynes, Lisa
AU - Rabbitt, Madeline
AU - Cunnane, Paul
AU - Schutte, Aletta E.
AU - Poulter, Neil R.
AU - McDonnell, Barry J.
N1 - © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
PY - 2024/6/1
Y1 - 2024/6/1
N2 - We participated in the UK and Republic of Ireland May Measurement Month 2021 (MMM21) campaign to raise awareness about blood pressure (BP) measurement and the dangers posed by elevated BP and hypertension. In addition, the campaign aimed to collect and report levels of BP awareness and control in the community setting. The MMM21 campaign set up opportunistic community screening sites at hospitals, general practice (GP) surgeries, community pharmacies, gyms, and various other public places. The campaign screened 1322 participants (mean age 46 years, 55% women) and found that 522 (39.5%) had hypertension (systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or on antihypertensive medication) at the time of testing. Of the 522 participants identified with hypertension, only 47.2% were aware of their condition. Of those on antihypertensive medication, only 45.7% had controlled BP (systolic BP < 140 mmHg and diastolic BP < 90 mmHg), and of all hypertensives, only 19.0% were controlled. Our UK and Ireland data continue to shed further light on low levels of awareness and control of hypertension in the UK and Ireland community setting. This evidence supports a critical need to further highlight the importance of identifying and taking action against raised BP.
AB - We participated in the UK and Republic of Ireland May Measurement Month 2021 (MMM21) campaign to raise awareness about blood pressure (BP) measurement and the dangers posed by elevated BP and hypertension. In addition, the campaign aimed to collect and report levels of BP awareness and control in the community setting. The MMM21 campaign set up opportunistic community screening sites at hospitals, general practice (GP) surgeries, community pharmacies, gyms, and various other public places. The campaign screened 1322 participants (mean age 46 years, 55% women) and found that 522 (39.5%) had hypertension (systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or on antihypertensive medication) at the time of testing. Of the 522 participants identified with hypertension, only 47.2% were aware of their condition. Of those on antihypertensive medication, only 45.7% had controlled BP (systolic BP < 140 mmHg and diastolic BP < 90 mmHg), and of all hypertensives, only 19.0% were controlled. Our UK and Ireland data continue to shed further light on low levels of awareness and control of hypertension in the UK and Ireland community setting. This evidence supports a critical need to further highlight the importance of identifying and taking action against raised BP.
KW - Blood pressure
KW - Control
KW - Hypertension
KW - Screening
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85199686362&partnerID=8YFLogxK
U2 - 10.1093/eurheartjsupp/suae060
DO - 10.1093/eurheartjsupp/suae060
M3 - Article
C2 - 39055583
AN - SCOPUS:85199686362
SN - 1520-765X
VL - 26
SP - iii96-iii98
JO - European Heart Journal, Supplement
JF - European Heart Journal, Supplement
IS - Supplement_3
ER -